Myriad Genetics Inc (MYGN)

Finanzdaten der Myriad Genetics Inc-Aktie (MYGN)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.85% 202.20	196.60	191.90	183.50	181.20
Cost Of Revenue	64.60	-	57.60	57.80	59.20
Gross Profit	137.60	-	134.30	125.70	122.00
Operating Expenses	58.89% 165.50	402.60	194.40	239.40	174.20
Interest Income/Expense	44.44% 0.50	0.90	1.00	0.50	0.50
Benefits Costs and Expenses	0.35% 228.10	228.90	253.10	299.60	233.80
Costs And Expenses	0.92% 230.10	228.00	252.00	297.20	233.40
Depreciation and Amortization	3.97% 15.70	15.10	14.10	13.30	19.40
Operating Income/Loss	11.15% -27.90	-31.40	-60.10	-113.70	-52.20
Nonoperating Income/Loss	322.22% 2.00	-0.90	-1.10	-2.40	-0.40
Income/Loss From Continuing Operations Before Tax	19.81% -25.90	-32.30	-61.20	-116.10	-52.60
Income Tax Expense/Benefit	109.09% 0.10	-1.10	0.10	-	2.10
Income/Loss From Continuing Operations After Tax	16.67% -26.00	-31.20	-61.30	-116.10	-54.70
Net Income/Loss	16.67% -26.00	-31.20	-61.30	-116.10	-54.70
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	7,392% 89.90	1.20	81.90	81.70	81.30
Diluted Average Shares	7,392% 89.90	1.20	81.90	81.70	81.30
Basic Earnings Per Share	14.71% -0.29	-0.34	-0.75	-1.42	-0.67
Diluted Earnings Per Share	14.71% -0.29	-0.34	-0.75	-1.42	-0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-